|
|
|
|
| LEADER |
01050Cam#a2200313#a#4500 |
| 001 |
OMD008955 |
| 003 |
OMD |
| 005 |
20141007130133 |
| 008 |
s2002 sz ||f |||| ||eng d |
| 020 |
# |
# |
|a 924153043X (OC)
|
| 022 |
# |
# |
|a 1234-56778
|
| 040 |
# |
# |
|a OMD
|b spa
|
| 060 |
# |
4 |
|a QV
|b 627
|
| 092 |
# |
# |
|s OMS
|c QV 627
|l WOR
|
| 110 |
2 |
# |
|a World Health Organization.
|
| 245 |
1 |
0 |
|a Acrolein /
|c World Health Organization and International Programme on Chemical Safety.
|
| 260 |
# |
# |
|a Geneva :
|b World Health Organization,
|c 2002.
|
| 300 |
# |
# |
|a iv, 46 p.
|
| 490 |
1 |
# |
|a WHO, Concise international chemical assessment document ;
|v 43
|
| 650 |
# |
7 |
|a Acroleína/efectos adversos
|2 Decs
|
| 650 |
# |
7 |
|a Acroleína/toxicidad
|2 Decs
|
| 650 |
# |
7 |
|a Organización Mundial de la Salud
|2 Decs
|
| 710 |
2 |
# |
|a International Programme on Chemical Safety.
|
| 830 |
# |
0 |
|a Concise international chemical assessment document, WHO. ;
|v 43
|
| 866 |
# |
0 |
|a 1 ej.
|
| 928 |
# |
# |
|a pre
|
| 928 |
# |
# |
|a enc
|
| 952 |
# |
# |
|p OMDF1932
|t ej.1
|a OMD
|b OMD
|o OMS QV 627 WOR [DEPOSITO]
|7 1
|y IMP
|
| 999 |
# |
# |
|a Claudia
|
